Concepedia
Statistics
Publications
13
Citations
563
H-Index
12
Active since
2011
Affiliations
Shenyang Pharmaceutical University(Current)
China Pharmaceutical University
Northwestern University
Qingdao University
China Medical University
Haonan Li is an author at Shenyang Pharmaceutical University specializing in medicine, pharmacology, and drug discovery.
Top concepts
MedicinePharmacologyChemistryBiochemistryTumor BiologyDrug DiscoveryCancer ResearchOxidative StressMedicinal ChemistryPathology
Publications per year
2011–2020
Small-molecule fluorescent probes for H2S detection: Advances and perspectives
Haonan Li, Yuxi Fang, Junjie Yan et al. · TrAC Trends in Analytical Chemistry · 2020 · 131 citations
H2s Detection, Chemistry, Chemical Probe +3
Inhibition of chronic pancreatitis and pancreatic intraepithelial neoplasia (PanIN) by capsaicin in LSL-KrasG12D/Pdx1-Cre mice
Hua Bai, Haonan Li, William Zhang et al. · Carcinogenesis · 2011 · 72 citations · Full text
Chemoprevention Strategy, Gastroenterology, Pathology +18
Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions
Kristina A. Matkowskyj, Han Bai, Jie Liao et al. · Human Pathology · 2013 · 64 citations · Full text
Aldoketoreductase Family 1B10, Benign Liver Lesions, Hepatology +11
Diversified strategies based on nanoscale metal-organic frameworks for cancer therapy: The leap from monofunctional to versatile
Xiangyu Ren, Yuxin Han, Yanqi Xu et al. · Coordination Chemistry Reviews · 2020 · 52 citations
Cancer Therapy, Nanomedicine, Nanoscale Metal-organic Frameworks +10
Knockdown or inhibition of aldo-keto reductase 1B10 inhibits pancreatic carcinoma growth via modulating Kras–E-cadherin pathway
Wanying Zhang, Haonan Li, Yihe Yang et al. · Cancer Letters · 2014 · 49 citations · Full text
Tumor Biology, Aldo-keto Reductase 1B10, Oncology +9
1–5 of 13